http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588775-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-04
filingDate 2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103588775-B
titleOfInvention Pralatrexate degradation impurity and preparation method thereof
abstract The present invention relates to Pralatrexate degradation impurity and preparation method thereof.Specifically, this Pralatrexate degradation impurity is N [4 [1 [(2 amino 4 hydroxyl 6 pteridyl) methyl] 3 butine 1 bases] benzoyl] the L glutamic acid shown in following formula (I).Its synthesis obtains target compound by being substituted by 4 [1 [(2,4 diaminourea 6 pteridyl) methyl] 3 butine 1 bases] benzoic acid compounds, be condensed, hydrolyzing.The method first passage chemosynthesis obtains formula (I) compound, and can be separated efficiently and rapidly and obtain target compound.
priorityDate 2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012074496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013096800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6028071-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9802163-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425836335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450837833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452458000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3939

Total number of triples: 50.